ACR Convergence 2024

November 14-19, 2024. Washington, DC.

View by Number View by Title View Sessions

Saturday, November 16, 2024

9:15AM-10:45AM: Plenary I

10:30AM-12:30PM: Antiphospholipid Syndrome Poster

10:30AM-12:30PM: B Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

10:30AM-12:30PM: Epidemiology & Public Health Poster I

10:30AM-12:30PM: Health Services Research – ACR/ARP Poster I

10:30AM-12:30PM: Healthcare Disparities in Rheumatology Poster I

10:30AM-12:30PM: Imaging of Rheumatic Diseases Poster I: Inflammatory Arthritis

10:30AM-12:30PM: Infection-related Rheumatic Disease Poster

10:30AM-12:30PM: Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I

10:30AM-12:30PM: Miscellaneous Rheumatic & Inflammatory Diseases Poster I

10:30AM-12:30PM: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster I

10:30AM-12:30PM: Osteoarthritis & Joint Biology – Basic Science Poster

10:30AM-12:30PM: Patient Education/Community Programs Poster – ARP

10:30AM-12:30PM: Patient Outcomes, Preferences, & Attitudes Poster I

10:30AM-12:30AM: Patient Perspectives Poster

10:30AM-12:30PM: Pediatric Rheumatology – Clinical Poster I

10:30AM-12:30PM: RA – Diagnosis, Manifestations, & Outcomes Poster I

10:30AM-12:30PM: RA – Etiology & Pathogenesis Poster

10:30AM-12:30PM: RA – Treatment Poster I

10:30AM-12:30PM: Reproductive Issues in Rheumatic Disorders Poster

10:30AM-12:30PM: SLE – Animal Models Poster

10:30AM-12:30PM: SLE – Diagnosis, Manifestations, & Outcomes Poster I

10:30AM-12:30PM: SLE – Treatment Poster I

10:30AM-12:30PM: SpA Including PsA – Basic Science Poster

10:30AM-12:30PM: SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster I

10:30AM-12:30PM: SpA Including PsA – Treatment Poster I

10:30AM-12:30PM: Systemic Sclerosis & Related Disorders – Clinical Poster I

10:30AM-12:30PM: Vasculitis – ANCA-Associated Poster I

10:30AM-12:30PM: Vasculitis – Non-ANCA-Associated & Related Disorders Poster I

1:00PM-2:30PM: Abstracts: B Cell Biology & Targets in Autoimmune & Inflammatory Disease I

1:00PM-2:30PM: Abstracts: Osteoarthritis – Clinical Trials

1:00PM-2:30PM: Abstracts: Pain in Rheumatic Disease Including Fibromyalgia

1:00PM-2:30PM: Abstracts: RA – Diagnosis, Manifestations, & Outcomes I: Breathe: RA-ILD

1:00PM-2:30PM: Abstracts: Reproductive Issues in Rheumatic Disorders

1:00PM-2:30PM: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes I: Omics

1:00PM-2:30PM: Abstracts: SpA Including PsA – Diagnosis, Manifestations, & Outcomes I

1:00PM-2:30PM: Abstracts: Systemic Sclerosis & Related Disorders – Basic Science

1:00PM-2:30PM: Abstracts: Vasculitis – ANCA-Associated I

3:00PM-4:30PM: Abstracts: Antiphospholipid Syndrome

3:00PM-4:30PM: Abstracts: Epidemiology & Public Health I

3:00PM-4:30PM: Abstracts: Imaging of Rheumatic Diseases

3:00PM-4:30PM: Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases I

3:00PM-4:30PM: Abstracts: Osteoarthritis – Novel Insights from Observational Studies

3:00PM-4:30PM: Abstracts: Pediatric Rheumatology – Basic Science

3:00PM-4:30PM: Abstracts: RA – Diagnosis, Manifestations, & Outcomes II: Bad Blood (Serologic and Imaging Biomarkers)

3:00PM-4:30PM: Abstracts: T Cell Biology & Targets in Autoimmune & Inflammatory Disease

3:00PM-4:00PM: Patient Perspectives

Sunday, November 17, 2024

9:00AM-10:30AM: Plenary II

10:30AM-12:30PM: Cytokines & Cell Trafficking Poster

10:30AM-12:30PM: Epidemiology & Public Health Poster II

10:30AM-12:30PM: Genetics, Genomics & Proteomics Poster

10:30AM-12:30PM: Health Services Research – ACR/ARP Poster II

10:30AM-12:30PM: Healthcare Disparities in Rheumatology Poster II

10:30AM-12:30PM: Innate Immunity Poster

10:30AM-12:30PM: Measures & Measurement of Healthcare Quality Poster

10:30AM-12:30PM: Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II

10:30AM-12:30PM: Miscellaneous Rheumatic & Inflammatory Diseases Poster II

10:30AM-12:30PM: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster II

10:30AM-12:30PM: Orthopedics, Low Back Pain, & Rehabilitation – ACR/ARP Poster

10:30AM-12:30PM: Osteoarthritis – Clinical Poster I

10:30AM-12:30PM: Pain in Rheumatic Disease Including Fibromyalgia Poster

10:30AM-12:30PM: Patient Outcomes, Preferences, & Attitudes Poster II

10:30AM-12:30PM: Pediatric Rheumatology – Clinical Poster II

10:30AM-12:30PM: Professional Education Poster

10:30AM-12:30PM: Psychology/Social Sciences Poster – ARP

10:30AM-12:30PM: RA – Diagnosis, Manifestations, & Outcomes Poster II

10:30AM-12:30PM: RA – Treatment Poster II

10:30AM-12:30PM: Research Methodology Poster – ARP

10:30AM-12:30PM: Rheumatoid Arthritis – Animal Models Poster

10:30AM-12:30PM: Sjögren's Syndrome – Basic & Clinical Science Poster I

10:30AM-12:30PM: SLE – Diagnosis, Manifestations, & Outcomes Poster II

10:30AM-12:30PM: SLE – Treatment Poster II

10:30AM-12:30PM: SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster II

10:30AM-12:30PM: SpA Including PsA – Treatment Poster II

10:30AM-12:30PM: Systemic Sclerosis & Related Disorders – Basic Science Poster I

10:30AM-12:30PM: Systemic Sclerosis & Related Disorders – Clinical Poster II

10:30AM-12:30PM: Vasculitis – ANCA-Associated Poster II

10:30AM-12:30PM: Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

1:00PM-2:30PM: Abstracts: B Cell Biology & Targets in Autoimmune & Inflammatory Disease II

1:00PM-2:30PM: Abstracts: Orthopedics, Low Back Pain, & Rehabilitation

1:00PM-2:30PM: Abstracts: Osteoarthritis & Joint Biology – Basic Science

1:00PM-2:30PM: Abstracts: Patient Outcomes, Preferences, & Attitudes I

1:00PM-2:30PM: Abstracts: RA – Etiology and Pathogenesis I

1:00PM-2:30PM: Abstracts: RA – Treatments: New Approaches

1:00PM-2:30PM: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes II: Biomarkers

1:00PM-2:30PM: Abstracts: Systemic Sclerosis & Related Disorders – Clinical I

1:00PM-2:30PM: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders I: Clinical Trials

3:00PM-4:30PM: Abstracts: Epidemiology & Public Health II

3:00PM-4:30PM: Abstracts: Health Services Research I

3:00PM-4:30PM: Abstracts: Immunological Complications of Medical Therapy

3:00PM-4:30PM: Abstracts: Innate Immunity: Molecular Insights Into Immune Dysregulation

3:00PM-4:30PM: Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science I

3:00PM-4:30PM: Abstracts: Professional Education

3:00PM-4:30PM: Abstracts: RA – Diagnosis, Manifestations, & Outcomes III: Best Day (RA Subpopulations)

3:00PM-4:30PM: Abstracts: SLE – Treatment I: Cellular Therapy

3:00PM-4:30PM: Abstracts: SpA Including PsA – Basic Science

3:00PM-4:30PM: Abstracts: SpA Including PsA – Treatment I

Monday, November 18, 2024

9:00AM-10:30AM: Plenary III

10:30AM-12:30PM: (L01–L14) Late-Breaking Posters

10:30AM-12:30PM: Epidemiology & Public Health Poster III

10:30AM-12:30PM: Health Services Research – ACR/ARP Poster III

10:30AM-12:30PM: Healthcare Disparities in Rheumatology Poster III

10:30AM-12:30PM: Imaging of Rheumatic Diseases Poster II

10:30AM-12:30PM: Immunological Complications of Medical Therapy Poster

10:30AM-12:30PM: Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster III

10:30AM-12:30PM: Miscellaneous Rheumatic & Inflammatory Diseases Poster III

10:30AM-12:30PM: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III

10:30AM-12:30PM: Osteoarthritis – Clinical Poster II

10:30AM-12:30PM: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

10:30AM-12:30PM: Patient Outcomes, Preferences, & Attitudes Poster III

10:30AM-12:30PM: Pediatric Rheumatology – Basic Science Poster

10:30AM-12:30PM: Pediatric Rheumatology – Clinical Poster III

10:30AM-12:30PM: RA – Diagnosis, Manifestations, & Outcomes Poster III

10:30AM-12:30PM: RA – Treatment Poster III

10:30AM-12:30PM: Sjögren's Syndrome – Basic & Clinical Science Poster II

10:30AM-12:30PM: SLE – Diagnosis, Manifestations, & Outcomes Poster III

10:30AM-12:30PM: SLE – Etiology & Pathogenesis Poster

10:30AM-12:30PM: SLE – Treatment Poster III

10:30AM-12:30PM: SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster III

10:30AM-12:30PM: SpA Including PsA – Treatment Poster III

10:30AM-12:30PM: Systemic Sclerosis & Related Disorders – Basic Science Poster II

10:30AM-12:30PM: Systemic Sclerosis & Related Disorders – Clinical Poster III

10:30AM-12:30PM: T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

10:30AM-12:30PM: Vasculitis – ANCA-Associated Poster III

10:30AM-12:30PM: Vasculitis – Non-ANCA-Associated & Related Disorders Poster III

1:00PM-2:30PM: Abstracts: ARP Interprofessional I: Epidemiology & Methods

1:00PM-2:30PM: Abstracts: Genetics, Genomics & Proteomics

1:00PM-2:30PM: Abstracts: Healthcare Disparities in Rheumatology

1:00PM-2:30PM: Abstracts: Metabolic & Crystal Arthropathies

1:00PM-2:30PM: Abstracts: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science

1:00PM-2:30PM: Abstracts: Pediatric Rheumatology – Clinical I

1:00PM-2:30PM: Abstracts: RA – Animal Models

1:00PM-2:30PM: Abstracts: SLE – Animal Models

1:00PM-2:30PM: Abstracts: SLE – Treatment II: Non-Cellular Lupus Therapeutics

1:00PM-2:30PM: Abstracts: SpA Including PsA – Treatment II

3:00PM-4:30PM: Abstracts: ARP Interprofessional II: Psychology & Practice

3:00PM-4:30PM: Abstracts: Cytokines & Cell Trafficking

3:00PM-4:30PM: Abstracts: Health Services Research II

3:00PM-4:30PM: Abstracts: Infection-related Rheumatic Disease

3:00PM-4:30PM: Abstracts: Measures & Measurement of Healthcare Quality

3:00PM-4:30PM: Abstracts: Pediatric Rheumatology – Clinical II

3:00PM-4:30PM: Abstracts: Sjögren's Syndrome – Basic & Clinical Science

3:00PM-4:30PM: Abstracts: SLE – Etiology & Pathogenesis

3:00PM-4:30PM: Abstracts: SpA Including PsA – Diagnosis, Manifestations, & Outcomes II

3:00PM-4:30PM: Abstracts: Systemic Sclerosis & Related Disorders – Clinical II

3:00PM-4:30PM: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders II

Tuesday, November 19, 2024

8:00AM-9:30AM: Late-Breaking Abstracts (L15–L20)

11:00AM-12:30PM: Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases II

11:00AM-12:30PM: Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science II

11:00AM-12:30PM: Abstracts: RA – Treatment II: Refining Use of Established Therapies

11:00AM-12:30PM: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes III: Targets, Outcomes & Comorbidity

11:00AM-12:30PM: Abstracts: Systemic Sclerosis & Related Disorders – Clinical III

11:00AM-12:30PM: Abstracts: Vasculitis – ANCA-Associated II

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].